Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 29.20M | $ 25.00M | $ 324.30M | $ 22.90M | $ 19.30M |
Total Assets | $ 1.96B | $ 1.75B | $ 1.63B | $ 1.33B | $ 611.20M |
Total Debt | $ 520.70M | $ 477.80M | $ 549.50M | $ 287.70M | $ 106.10M |
Net Debt | $ 491.50M | $ 452.80M | $ 225.20M | $ 264.80M | $ 86.80M |
Total Liabilities | $ 897.40M | $ 816.90M | $ 768.80M | $ 507.50M | $ 229.90M |
Stockholders Equity | $ 1.06B | $ 931.20M | $ 862.30M | $ 819.20M | $ 381.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |